Celularity Inc
CELUW
21 hedge funds and large institutions have $4.95M invested in Celularity Inc in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
5% less funds holding
Funds holding: 22 → 21 (-1)
20% less capital invested
Capital invested by funds: $6.16M → $4.95M (-$1.21M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
Top Sellers
| 1 |
CC
Centiva Capital
New York
|
-$33.3K |
| 2 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$20K |
| 3 |
CAC
Cowen and Company
New York
|
-$2.06K |
| 4 |
KC
Kepos Capital
New York
|
-$685 |
CELUW Hedge Fund Activity: Q1 2020 in Review
21 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Celularity Inc (CELUW) for Q1 2020, worth a combined $4.95M — down 20% from $6.16M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CELUW and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 5 added.
The largest buyer was Basso Capital Management, adding an estimated $217K. The largest seller was Centiva Capital, exiting entirely with an estimated $33.3K sold.
- 21 institutional investors held Celularity Inc (CELUW) as of Q1 2020, down from 22 in Q4 2019.
- Funds reported $4.95M of Celularity Inc stock for Q1 2020, down 20% quarter-over-quarter.
- 1 fund opened new Celularity Inc positions in Q1 2020 and 2 closed out, a net change of -1 holder.
- The largest Celularity Inc buyer in Q1 2020 was Basso Capital Management, an estimated $217K added.
- The largest Celularity Inc seller in Q1 2020 was Centiva Capital, an estimated $33.3K sold.
Based on aggregated 13F filings for Q1 2020.